Ovarian cancer

• Science & Technology
• Health & Medicine

News digest – children who smoke, pancreatic cancer, abiraterone in Wales, and more

24 February 2012

• Science & Technology
• Health & Medicine

News digest: Tasmanian devils, smoking bans, internet health info, and more

18 February 2012

• Science & Technology
• Health & Medicine

Podcast: New drugs, earlier diagnosis, and an interview with our chief executive

14 February 2012

Scientists reveal best imaging technique for ovarian cancer

Cancer Research UK-funded scientists have determined that a magnetic resonance imaging (MRI) technique, which measures the movement of water molecules within the tumour, may be the best way to monitor how women with late-stage ovarian cancer are responding to treatment. The study is published in the journal Radiology today. Cancer Research UK-funded scientists have determined that a magnetic resonance imaging (MRI) technique, which measures the movement of water molecules within the tumour, may be the best way to monitor how women with late-stage ovarian cancer are responding to treatment. The study is published in the journal Radiology today.

14 February 2012

• Health & Medicine

Women with faulty BRCA genes more likely to survive ovarian cancer

Ovarian cancer patients who carry BRCA1 or BRCA2 mutations are significantly more likely to survive the disease than women without these faulty genes, according to research published in the Journal of the American Medical Association. Ovarian cancer patients who carry BRCA1 or BRCA2 mutations are significantly more likely to survive the disease than women without these faulty genes, according to research published in the Journal of the American Medical Association.

24 January 2012

• Science & Technology
• Health & Medicine

News digest – oesophageal cancer, HRT, Leveson and more

21 January 2012

Cancer Research UK launches 'outpatients' trial of breast and ovarian cancer drug

Cancer Research UK's Drug Development Office has re-launched a trial of a promising drug to treat inherited breast and ovarian cancer - but this time taken as a tablet by outpatients. Cancer Research UK's Drug Development Office has re-launched a trial of a promising drug to treat inherited breast and ovarian cancer - but this time taken as a tablet by outpatients.

11 January 2012

Evolving ovarian cancer cells 'dodge' treatment with chemotherapy

Cancer Research UK scientists have discovered that the commonest type of ovarian cancer evolves at a startling rate, which may allow cancer cells to 'dodge' the current standard treatment, reveals research in The Journal of Pathology today. Cancer Research UK scientists have discovered that the commonest type of ovarian cancer evolves at a startling rate, which may allow cancer cells to 'dodge' the current standard treatment, reveals research in The Journal of Pathology today.

19 December 2011

• Health & Medicine

First patients enrolled in project to improve NHS cancer gene testing

Cancer Research UK has started recruiting patients for a pioneering initiative to demonstrate how genetic tests could be used within the NHS to help match cancer patients to the most appropriate treatment, while building a database of information for research into new targeted therapies. Cancer Research UK has started recruiting patients for a pioneering initiative to demonstrate how genetic tests could be used within the NHS to help match cancer patients to the most appropriate treatment, while building a database of information for research into new targeted therapies.

21 November 2011

• Health & Medicine

The Pill, pregnancy and cancer – making sense of the headlines

26 October 2011